BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 15549145)

  • 1. Acadesine induces apoptosis in B cells from mantle cell lymphoma and splenic marginal zone lymphoma.
    Campàs C; Santidrián AF; Domingo A; Gil J
    Leukemia; 2005 Feb; 19(2):292-4. PubMed ID: 15549145
    [No Abstract]   [Full Text] [Related]  

  • 2. Synergistic anti-tumor activity of acadesine (AICAR) in combination with the anti-CD20 monoclonal antibody rituximab in in vivo and in vitro models of mantle cell lymphoma.
    Montraveta A; Xargay-Torrent S; López-Guerra M; Rosich L; Pérez-Galán P; Salaverria I; Beà S; Kalko SG; de Frias M; Campàs C; Roué G; Colomer D
    Oncotarget; 2014 Feb; 5(3):726-39. PubMed ID: 24519895
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of adenosine concentrations by acadesine (AICA-riboside) in human B-lymphoblasts.
    Barankiewicz J; Jimenez R; Uyesaka J; Gruber HE
    Adv Exp Med Biol; 1991; 309A():275-8. PubMed ID: 1789225
    [No Abstract]   [Full Text] [Related]  

  • 4. Higher levels of surface CD20 expression on circulating lymphocytes compared with bone marrow and lymph nodes in B-cell chronic lymphocytic leukemia.
    Huh YO; Keating MJ; Saffer HL; Jilani I; Lerner S; Albitar M
    Am J Clin Pathol; 2001 Sep; 116(3):437-43. PubMed ID: 11554173
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Composite splenic marginal zone lymphoma and mantle cell lymphoma arising from 2 independent B-cell clones.
    Lefebvre C; Fabre B; Vettier C; Rabin L; Florin A; Wang J; Gressin R; Jacob MC; Callanan M; Leroux D
    Hum Pathol; 2007 Apr; 38(4):660-7. PubMed ID: 17134739
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acadesine: a unique cardioprotective agent for myocardial ischemia.
    Nawarskas JJ
    Heart Dis; 1999; 1(4):255-60. PubMed ID: 11720632
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 5-Aminoimidazole-4-carboxamide riboside induces apoptosis in Jurkat cells, but the AMP-activated protein kinase is not involved.
    López JM; Santidrián AF; Campàs C; Gil J
    Biochem J; 2003 Mar; 370(Pt 3):1027-32. PubMed ID: 12452797
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Auer rod-like inclusions in the cytoplasm of splenic lymphoma cells.
    Zhu J; Zhang C; Guo W; Li F; Zou S; Pan B
    Leuk Lymphoma; 2014 Nov; 55(11):2663-4. PubMed ID: 24576169
    [No Abstract]   [Full Text] [Related]  

  • 9. 5-aminoimidazole-4-carboxamide riboside enhances effect of ionizing radiation in PC3 prostate cancer cells.
    Isebaert SF; Swinnen JV; McBride WH; Begg AC; Haustermans KM
    Int J Radiat Oncol Biol Phys; 2011 Dec; 81(5):1515-23. PubMed ID: 21944462
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytokine gene expression in neoplastic B cells from human mantle cell, follicular, and marginal zone lymphomas and in their postulated normal counterparts.
    Airoldi I; Guglielmino R; Ghiotto F; Corcione A; Facchetti P; Truini M; Pistoia V
    Cancer Res; 2001 Feb; 61(4):1285-90. PubMed ID: 11245421
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acadesine improves tolerance to ischemic injury in rat cardiac myocytes.
    Gruver EJ; Toupin D; Smith TW; Marsh JD
    J Mol Cell Cardiol; 1994 Sep; 26(9):1187-95. PubMed ID: 7815461
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acadesine: preclinical overview.
    Gruber HE
    Adv Exp Med Biol; 1994; 370():423-6. PubMed ID: 7660942
    [No Abstract]   [Full Text] [Related]  

  • 13. Acadesine (AICA riboside) attenuates reperfusion injury and oxidant-induced damage of the heart.
    Metzner EK; Fox MH; Potter S; Mullane KM; Bullough DA
    Adv Exp Med Biol; 1991; 309A():347. PubMed ID: 1789240
    [No Abstract]   [Full Text] [Related]  

  • 14. Primary splenic lymphoma: does it exist?
    Gobbi PG; Grignani GE; Pozzetti U; Bertoloni D; Pieresca C; Montagna G; Ascari E
    Haematologica; 1994; 79(3):286-93. PubMed ID: 7926983
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Splenic marginal zone lymphomas appear to originate from different B cell types.
    Bahler DW; Pindzola JA; Swerdlow SH
    Am J Pathol; 2002 Jul; 161(1):81-8. PubMed ID: 12107092
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence of phenotypic aberrations in a series of 467 patients with B chronic lymphoproliferative disorders: basis for the design of specific four-color stainings to be used for minimal residual disease investigation.
    Sánchez ML; Almeida J; Vidriales B; López-Berges MC; García-Marcos MA; Moro MJ; Corrales A; Calmuntia MJ; San Miguel JF; Orfao A
    Leukemia; 2002 Aug; 16(8):1460-9. PubMed ID: 12145686
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coexisting follicular and mantle cell lymphoma with each having an in situ component: A novel, curious, and complex consultation case of coincidental, composite, colonizing lymphoma.
    Roullet MR; Martinez D; Ma L; Fowler MH; McPhail ED; Judkins A; Arber DA; Bagg A
    Am J Clin Pathol; 2010 Apr; 133(4):584-91. PubMed ID: 20231612
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Histopathologic features of splenic small B-cell lymphomas. A study of 42 cases with a definitive diagnosis by the World Health Organization classification.
    Kansal R; Ross CW; Singleton TP; Finn WG; Schnitzer B
    Am J Clin Pathol; 2003 Sep; 120(3):335-47. PubMed ID: 14502797
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Marginal zone lymphomas, MALT and splenic types.
    De Wolf-Peeters C
    Adv Clin Path; 2000 Oct; 4(4):190-2. PubMed ID: 11436156
    [No Abstract]   [Full Text] [Related]  

  • 20. AICA-riboside (acadesine), an activator of AMP-activated protein kinase with potential for application in hematologic malignancies.
    Van Den Neste E; Van den Berghe G; Bontemps F
    Expert Opin Investig Drugs; 2010 Apr; 19(4):571-8. PubMed ID: 20367195
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.